CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

72
CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College

Transcript of CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Page 1: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

CHAPTER 3Drug Development

Page 2: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Learning Objectives• Define the term drug and distinguish between active and

inert ingredients.• Identify several scientific discoveries of medications that

improved individuals’ quality of life and life span.• Define the terms drug tolerance, psychological

dependence, and physical dependence.• Contrast the regulation and labeling requirements for

over-the-counter drugs, homeopathic medications, and dietary supplements.

• Categorize drugs according to their various sources: natural, synthetic, synthesized, or semisynthetic.

Page 3: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Learning Objectives• Define the term pharmacogenomics and its future impact

on drug development and dosing.• Understand the classifications that describe the various

uses of drugs: therapeutic, pharmacodynamic, diagnostic, prophylactic, and destructive agents.

• Discuss the process and role of the Food and Drug Administration (FDA) and the United States Pharmacopeia in the marketing of new pharmaceutical products.

• Review statistics and costs of getting a new investigational drug to market.

Page 4: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Learning Objectives• Understand the process for FDA approval for generic drugs,

and define the terms bioequivalence and therapeutic equivalence.

• Explain the parts of a National Drug Code number and its use by the pharmacy technician.

• Identify the three classes of FDA drug recalls.• Identify the major sources of consumer and professional drug

information.• Understand postmarketing surveillance reporting programs for

medication and product safety.• List four drugs that are subject to risk evaluation and

mitigation strategies, for their safe use.• Identify the function of various commonly used

pharmaceutical reference texts.

Page 5: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Introduction• Technological advances in pharmaceuticals have

transformed people’s lives.• The development of these drugs was built on a scientific

framework provided by earlier major research discoveries.• Pharmacology – the study of how drugs work inside the

body.• Improved regulations of drugs, lengthy drug trials testing

the efficacy and safety of medications before they are marketed.

Page 6: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

What Is a Drug?• Drug: substance taken into or applied to the body for the

purpose of altering the body’s biochemical functions and thus its physiological processes.

Page 7: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

What Is a Drug?• Early civilizations drugs were derived from plant sources

and were compounded into powders, extracts, and tinctures.• Herbal remedies continue to be used today.• Scientific advancements in chemistry, anatomy and

physiology, pathophysiology and genetics have led to the development of more potent and toxic medications.

• Today’s drugs include:• Dietary supplements – vitamins, minerals, and herbs• Homeopathic remedies• Over-the-counter (OTC)• Prescription

• Drugs are available as brand and/or generic and can be classified as controlled substances.

Page 8: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

What Is A Drug?• Drugs can contain one or more active ingredients that

have specific therapeutic uses.• Active ingredient – the biochemically active component

of the drug that exerts the desired therapeutic effect – desired pharmacological action of a drug on the body.

• Drugs also contain one or more inactive or inert ingredients.

• Inert ingredient – has little or no physiological effect on the body.

• What are some examples of common inert ingredients?• Inert ingredients stabilize the formulation; provide raw

material; ensure sterility; mask unpleasant tastes.

Page 9: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Significant Drug Discoveries• What would our lives be like without vaccines, insulin,

penicillin, the birth control pill, or HIV medication?

Page 10: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Smallpox – The First Vaccination• 1796 Dr. Edward Jenner performed the first experimental

vaccination.• Dairy workers who had been exposed to cowpox were

immune to smallpox.• Jenner realized cowpox exposure provided immunity to

smallpox.• Antibody – the part of the body’s immune system that

neutralizes antigens or foreign substances.• Jenner introduced bacteria from a cowpox lesion into a

healthy individual and discovered that the healthy individual did not contract smallpox despite exposure.

Page 11: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Smallpox – The First Vaccination• Jenner coined the term vaccination, a term that comes

from the Latin word vacca – meaning cow.• Vaccine – a substance introduced into the body to

produce immunity to disease.• Smallpox was the first disease in history to be eradicated.• Early vaccinations had high complication rates due to

problems with purity and mass production.• Today, drug consistency is virtually guaranteed, and

vaccines are quite safe.• Pharmacists in many community pharmacies can now

administer vaccines.

Page 12: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Insulin – A Lifesaver!• Sir Frederick Banting and Charles Best – discovered insulin

while experimenting with beagles.• Previous research showed a link between the pancreas and

diabetes – “the sugar disease.”• Dogs with diabetes were kept alive with an extract from the

pancreas, isletin.• This extract was later isolated and purified and named

insulin after the Latin word island.• Hailed as one of the most significant advances to medicine

at the time.• Discovery of this drug extended the lives of millions of

people; today more than 15 million diabetic patients live near-normal lives.

Page 13: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Penicillin – The First Antibiotic• Antibiotic: a chemical substance that kills or inhibits the

growth of bacteria.• 1928, Dr. Alexander Fleming, discovered penicillin by

accident.• https://www.google.com/url?url=http://

www.youtube.com/watch%3Fv%3DZxMq1YAa4qE&rct=j&sa=X&ei=VXB9UMrTKMa_qgGeg4DwDQ&ved=0CD8QuAIwBA&q=video+of+fleming+and+pencillin&usg=AFQjCNFB6Nl_at9csL6HMeT9p-4VysW1ew

• Fleming isolated an extract from the bacteria-killing mold; identified it from the Penicillium genus; named the agent penicillin.

Page 14: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Penicillin – The First Antibiotic• Penicillin saved many soldiers’ lives during WWII.• 1945, penicillin could be mass produced and brought to

the market.• Today, there are hundreds of synthetic antibiotics, but

continual research is needed to overcome bacterial resistance.

• The stronger the dose of antibiotics, creates a higher risk of side effects.

• Due to drug resistance, the required dose to threat an ear infection, with amoxicillin, has doubled in the past 30 years.

Page 15: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

The Scourge of Polio• One of the most destructive diseases of the 20th century.• Polio is characterized by muscle weakness and paralysis

of lower extremities.• Typically children were affected by polio; left with residual

paralysis requiring braces and crutches for life.• 1952 – 21,000 cases of the most serious form of polio –

paralytic polio – were reported in the U.S.• Iron lung – a noninvasive negative-pressure ventilator,

was used to treat severe symptoms by artificially maintaining respiration during acute polio infection until the patient could breath independently.

Page 16: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

The Scourge of Polio• 1953, American physician Jonas Salk created an

injectable vaccine from animal cultures that contained the killed viruses of three kinds of polio.

• Salk developed a process using formalin, a chemical that inactived or killed the whole virus.

• A “killed” vaccine does not transmit or contain a live virus.• Mass immunization programs were initiated in 1955, that

year there were 28,000 reported cases of polio.• One year later, there were only 15 cases of polio.• 1994, polio was declared eradicated in all of the Americas;

world-wide cases have dropped from hundreds of thousands to just under a thousand today.

Page 17: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

The Pill• Few contraceptive methods existed before the pill.• 1930’s research on reproductive biology identified the

female sex hormones estrogen and progesterone and understanding of their functions.

• Research continued though funding was scarce, and the hormones were difficult and expensive to synthesize.

• Early approved birth control pills contained high doses of both estrogen and progesterone to ensure prevention of pregnancy.

• High doses contributed to high incidences of side effects including nausea, headache, and blood clots.

Page 18: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

The Pill• Over time and with additional research the dosages of sex

hormones have been decreased, reducing the risk of adverse effects.

• Written patient information on the risk of the pill must be included with each dispensed birth control prescription.

• An estimated 100 million women worldwide today are on the pill.

• Many different combinations and names of brand and generic birth controls are on the market.

• When taken appropriately, the pill is 99%+ effective in preventing pregnancy.

Page 19: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

HIV/AIDS• 1980’s saw the emergence of a formidable virus – the

human immunodeficiency virus (HIV) – when epidemiologists noted an outbreak of rare pneumonia and cancers in New York City.

• 1983, HIV is independently isolated and verified by the Pasteur Institute in France and the National Cancer Institute in the U.S.

• This virus progressively attacks the immune system causing the development of acquired immunodeficiency syndrome (AIDS).

• Transmitted through bodily fluids during sexual contact, intravenous drug use, or tainted blood transfusions.

Page 20: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

HIV/AIDS• Lifetime treatment of HIV is estimated at more than

$400,000 per person.• 1987, the first antiviral drug to treat HIV was approved by

the FDA. Since 1987, many additional oral and injectable HIV drugs have been developed.

• Combination therapy of three to four drugs is currently the common prescribed treatment to control the virus.

• Vaccines have so far been infective; medications give to a pregnant HIV-infected patient have been shown to be effective in reducing transmission to a newborn at delivery.

Page 21: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

HIV/AIDS• HIV drugs have many adverse side effects, are expensive

and can interact with many medications.• Diagnosis of HIV or AIDS, in the early years of the

disease, was considered a death sentence.• Approximately 50,000 cases of HIV/AIDS are reported

each year; more than 1.2 million people live with the disease in the U.S. alone.

• Regimented medication therapy allows many of those affected to live near-normal lives.

Page 22: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Sources of Drugs• Drugs are derived from various sources and can be

classified as:• Natural• Synthetic – created artificially• Synthesized – created artificially but in imitation of

naturally occurring substances• Semisynthetic – containing both natural and synthetic

components• Biogenetically engineered drugs are a major source of

new drug development in the 21st century.

Page 23: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Natural Sources of Drugs• Some drugs are naturally occurring biological products made

or taken from single-celled organisms, plants, animals, minerals, and humans.

Laboratory Sources of Drugs• Many naturally occurring substances have been combined with

other ingredients to produce synthetic, synthesized, and semisynthetic drugs.

• Synthetic Drugs – a drug that has been created from a series of chemical reactions to produce a specific pharmacological effect; phenobarbital, sulfa antibiotic.

• Synthesized Drugs – a drug created artificially in the laboratory but in imitation of a naturally occurring drug; epinephrine hydrochloride (EpiPen); digoxin, aspirin and quinine; many antibiotics.

• What other synthesized drugs exist today?

Page 24: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Laboratory Sources of Drugs• Semisynthetic Drugs – a natural drug that has been

chemically modified in the laboratory to do one or more of the following actions:

• (1) improve the efficacy of the natural product• (2) reduce its side effects• (3) overcome developing bacterial resistance• (4) broaden the spectrum of bacteria that can be treated• Many antibiotics are modifications of existing natural

drugs.• These antibiotics are more effective against different

strains of bacteria or bacteria that have developed resistance to the natural product.

Page 25: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Biogenetically Engineered Drugs• Biotechnology – combines the science of biology, chemistry,

and immunology to produce synthetic, unique drugs with specific therapeutic effects.

• These drugs can be created by the means of recombinant DNA techniques.

• Deoxyribonucleic acid (DNA) – is the complex, helically shaped molecule that carries the genetic code.

• DNA is made up of four base pairs; A, T, C and G; repeated millions/billions of times throughout a genome.

• Genome – the entire DNA in an organism, including its genes.• The DNA contains directions for creating messenger

ribonucleic acid (RNA) – contains arranged sequences for making amino acids into proteins.

Page 26: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Biogenetically Engineered Drugs• Proteins determine how an organism looks, how its body

metabolizes drugs or fights infections, and how it might behave.

• A defect in DNA might increase the risk for developing certain diseases.

• Genetic engineering – the process of utilizing DNA biotechnology to create a wide variety of drugs.

• Biotechnology has led to a new field of study blending two areas of science: pharmacology and genomics.

• Pharmacogenomics – this field of study examines the relationship between an individual’s genes and his or her body’s response to drugs.

Page 27: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Biogenetically Engineered Drugs• The vision of pharmacogenomics is to design and

produce drugs that cater to an individual’s genetic makeup.

• Genetic engineering would specify drugs like blood thinners, that would produce the intended pharmacological effect without the additional risk of adverse reactions.

• More than 900 biogenetically engineered drugs are under development currently.

Page 28: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Classifications• Drugs are classified by the FDA as:

• Prescription• Over-the-counter (OTC)• Homeopathic• Dietary supplements (not directly regulated by the FDA)

• Vitamins• Minerals• Herbs

• Pharmacy personnel must have a solid understanding of the different state and federal laws regarding the dispensing, marketing and sale of these drugs.

Page 29: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Prescription Drugs• Prescription drug – formerly known as a legend drug,

can only be dispensed upon receipt of a prescription from a licensed healthcare professional in a state.

• All prescription drugs are labeled “Rx only.”• Prescription drugs are available as brand name or

generic.• Why is it important for you as a pharmacy technician to

know brand and generic drug names?

Page 30: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Controlled Substances• Some prescription drugs are classified as controlled

substances by the Controlled Substances Act of 1970.• Drugs are organized into five schedules or classes

according to their potential for abuse and addiction.• Which schedule has the highest potential for abuse?• Drug tolerance – a condition in which the body adapts to

a drug so that higher doses are needed to produce the same therapeutic effect achieved earlier with lower doses.

• Drug tolerance can lead to psychological, physical dependence, or drug addiction.

Page 31: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Controlled Substances• Psychological dependence – a condition in which a

patient takes a drug on a regular basis because it produces a sense of well-being.

• Patients can experience anxiety or withdrawal symptoms if they stop taking the drug.

• Physical dependence – taking a drug continuously so that when the medication is stopped, physical withdrawal symptoms occur.

• Addiction – compulsive and uncontrollable use of controlled substances. Addicted patients will do anything to support their drug habit.

• Technicians must review carefully prescriptions for controlled substances.

Page 32: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

OTC Drugs• Over-the-counter (OTC) drugs – a drug that can be

purchased without a prescription.• OTC drugs must be recognized as safe and effective by

the FDA when labeled directions on the container are followed.

• Most OTC drugs are indicated for short-term therapy (7 days) and self-limited conditions.

• Some OTC drugs can be used long-term with physician approval.

• Many OTC drugs were once prescription drugs approved by the FDA after expiration of the manufacturer’s patent.

Page 33: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

OTC Drugs• What are some examples of OTC drugs that were once

prescription drugs?• OTC drugs must have adequate labeling, written in easily

understood terms, to assist the customer in proper usage, assuming no contact with a pharmacist or typed directions from a physician.

• Labels must contain “Drug Facts” box listing active ingredients, purposes, use of the product, warnings and directions for age-appropriate dosing.

• Drug labels must also have an expiration date as well as list of inactive ingredients.

Page 34: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

OTC Drugs• Some OTC drugs and supplies are sold “behind the

counter.”• Pseudoephedrine

• Federal and state laws and regulations controlling the dispensing• http://www.mffh.org/mm/files/methmissourireport.pdf (pg. 13)

• Plan B (no longer restricted to “behind the counter)• Age restrictions

• Insulin syringes• Possible abuse/diversion

• Certain asthma medications• Additional need for pharmacist counseling

Page 35: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Homeopathic Medications• Homeopathic medications – use of subclinical doses of

natural extracts or alcohol tinctures to stimulate the body’s own immune system to overcome the specifically targeted symptom.

• Homeopathy is derived from the Greek root words homos – “similar” and pathos – “suffering or disease.”

• Most homeopathic medications are OTC, some however are considered prescription only.

• Homeopathic medications use was popular in the early 19th century and remains popular in parts of Europe.

• “Natural treatments” is another designation of homeopathic medications; minimal risk of side effects.

Page 36: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Dietary Supplements• Dietary supplements: vitamins, minerals, herbs.• Dietary supplement – exerts weak pharmacological effects

on the body similar to drugs.• Dietary supplements can cause side effects, adverse

reactions, and drug interactions.• Dietary supplements are considered “food supplements”

that maintain health.• Consumers should not exceed the recommended daily dose

or “serving size.”• The FDA can only regulate dietary supplements when

patient safety concerns exist.• Technicians need to gather information from patients about

their use of herbs or other dietary supplements.

Page 37: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

USP and Dietary Supplements• The USP Verified Mark is placed on dietary supplements when

the quality of the product has been verified under the USP’s dietary supplement verification program.

• The dietary supplement:• Contains ingredients listed on its labels, in the declared potency and

amounts; does not contain harmful levels of specified contaminants; has been made according to FDA good manufacturing practices (GMPs)

• Process of USP Verification: is a voluntary comprehensive testing and evaluation process done by participating manufacturer’s.

• What sorts of things are USP’s staff scientists looking at when verifying a dietary supplement?

• USP’s standard are FDA-enforceable per the Federal Food, Drug, and Cosmetic Act.

Page 38: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Use of Drugs• Medications not only treat and cure illnesses but aid in

their diagnosis and prevent onset.• Pharmacy technicians must be familiar with the

therapeutic uses of commonly prescribed drugs.• Several classifications for uses of drugs exist, most of

these categories are not mutually exclusive.• Classifications include:

• Therapeutic agents• Pharmacodynamic agents• Diagnostic agents• Prophylactic agents• Destructive agents

Page 39: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Therapeutic Agents• Therapeutic agent – a drug that targets a specific need

in the body.• Maintaining health

• Regulate metabolism; contribute to the maintenance of normal growth and function

• Relieving symptoms• Anti-inflammatory drugs; narcotics; diuretic (water pills)

• Combating illness• Antibiotics; antiviral medications; drugs for Alzheimer’s disease

• Reversing disease processes• Medications that control depression, blood pressure and

cholesterol

Page 40: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Pharmacodynamic Agents• Pharmacodynamic agent – a medication that alters body

functioning in a desired way.• Pharmacodynamic agents can be used to relax muscles,

dilate pupils, or change blood glucose levels.• Caffeine is considered a pharmacodynamic agent. Why?• What other examples are there of pharmacodynamic

agents?

Page 41: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Diagnostic Agents• Diagnostic agent – a chemical containing radioactive

isotopes that is used to diagnose or treat disease.• Isotopes are forms of an element that contain the same

number of protons but different number of neutrons.• Unstable radioactive isotopes give off energy in the form of

radiation.• Isotopes can be used as tracers, helping pinpoint, diagnose

and treat certain disorders.• Radiopharmaceuticals – is working with radioactive

isotopes, and is a specialized area of pharmacy practice; nuclear pharmacy.

• Specialized training and certification is required to work with these agents.

Page 42: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Prophylactic Agents• Prophylactic agent – prevents illness or disease from

occurring.• Prophylactic agents include:

• Antiseptic and germicidal liquid chemicals for pre-operative hand washing procedures

• Vaccines• Influenza; mumps; hepatitis• Pneumonia; rubella• Shingles; chicken pox• Tetanus; smallpox• Measles; poliomyelitis

• Antibiotics

Page 43: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Destructive Agents• Destructive agent – has a – cidal action; it kills bacteria,

fungi, viruses – normal and abnormal cancer cells.• Radioactive iodine

• Many antibiotics, given in high doses and/or IV infusions are bactericidal – these agents kill rather than inhibit bacteria that are sensitive to these drugs.• Penicillin

• Antineoplastic drug – a drug used in cancer chemotherapy to destroy malignant tumor.

• Different antineoplastic drugs used in combination to slow the growth of cancer cells, at different phases.

Page 44: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Destructive Agents• Most of these drugs cannot distinguish, effectively,

between cancer and normal cells.• Side effects like hair loss, immunosuppression, and

ulcerations of the mouth or GI tract commonly occur.• Agents used in cancer chemotherapy are considered

hazardous drugs.• These drugs require special storage, preparation, and

monitoring.• Additional and specialized training is required to work with

these destructive agents.

Page 45: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

United States Pharmacopeia

• The United State Pharmacopeia (USP) was charged in 1938 by Congress to develop official compendia and public standards for all prescription and OTC drugs marketed in the U.S.

• Today, they continue to develop authoritative, unbiased information on drug quality and disseminates this information to help healthcare professionals.

• United States Pharmacopeia – National Formulary (USP – NF) contains standards for medicines, dosage forms, drugs substances, etc.

• A manufactured drug product must conform to these standards to avoid possible charges of adulteration, misbranding and to be considered for approval by the FDA.

Page 46: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Food and Drug Administration• The FDA assurers the American public that drugs that are

approved are both safe and effective.• New drugs must meet strict standards and undergo a

fairly lengthy and expensive research process before coming to market.

• Stringent regulations were developed in response to medication tragedies involving the drug thalidomide.

• Technicians need to be aware of the FDA approval process which includes:• Development of brand name drugs• Bioequivalent generics• Packaging and labeling• Continuing oversight by the FDA

Page 47: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Approval Process• Regulations for manufacturers while researching new chemical

entities and developing those chemicals into brand or trade name drugs.

• Before an investigational new drug application (INDA) is reviewed by the FDA or clinical trials are initiated; extensive preclinical animal lab research must be done; once an investigational new drug (IND) is approved by the FDA and the study is approved by the institutional review board (IRB), human trials may begin.

• Human Use Committee reviews, approves and monitors all medical research involving humans.

• Informed consent – a document that must be signed by each research subject, that states, in easily understandable terms, the purpose and risk of the research.

Page 48: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Clinical Studies• Three phases of clinical studies:• Phase 1 – initial study or trial of new drugs in humans

• Small number of healthy volunteers• Gather sufficient data concerning the drug’s actions and potential

side effects

• Phase 2 – evaluate the effectiveness and safety of a drug for a given indication or disease state• Small number of patients• Well controlled and closely monitored by FDA

• Phase 3 – larger clinical trials• Better assess the benefits and risks of the investigational drug on

patients

Page 49: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

New Drug Application for Brand Name Drugs

• After a promising Phase 3 studies, the pharmaceutical manufacturer can apply for a new drug application (NDA).

• The NDA must prove the case for both the safety and effectiveness of the drug.

• Scientific studies are evaluated and recommendations are forwarded to the FDA.

• If the benefit of the drug outweighs the risks, generally the drug is approved; the approval process may take a year or longer.

• FDA can opt to fast-track a drug if it shows to be very promising early on in testing.

Page 50: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

New Drug Application for Brand Name Drugs

• Drug development is risky as well as costly.• 5,000 to 10,000 screened compounds; 250 of which enter

preclinical research testing; 5 enter human trials; 1 new compound is approved.

• Cost of development: more than 1 billion dollars.• Taking an average of 15 years of research and

development.• Patent protection on new drugs provides financial

incentive for manufacturers.

Page 51: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Abbreviated New Drug Application for Generic Drugs• Generic drug – contains the same active ingredient as

the brand name product and delivers the same amount of medication to the body in the same way and in the same amount of time.

• More than 1 billion generic drugs are dispensed every year; approximately 80% of all prescription drugs.

• This number is expected to rise to 85% by 2016 as more brand name drugs go “off patent.” (See table 3.1)

• Once a patent is due to expire, a generic pharmaceutical company can submit an abbreviated new drug application (aNDA).

Page 52: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Abbreviated New Drug Application for Generic Drugs• These drug applications are termed “abbreviated”

because they generally are not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness.

• Generic applicants must prove scientifically that their product is bioequivalent – or performs in the same manner as an already approved brand name drug.

• Bioavailability - the time it takes the generic drug to reach the bloodstream and exert a pharmacological effect on healthy volunteers, is one way that scientists demonstrate bioequivalence.

• Bioavailability includes how a drug is absorbed, metabolized, distributed or eliminated from the body.

Page 53: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Cost Savings of Generic Drugs• Most insurance plans encourage cost saving measures,

this includes the use of generic drugs unless a physician states “brand name drug necessary.”

• Generics offer cost savings of 30% to 80% over their brand name counterparts.

• 2010, the average co-pay for generics was just over six dollars; preferred and nonpreferred brand name drugs were four to five times higher.

• Generic manufacturers are granted a 180-day exclusivity period by the FDA for one or more manufacturers of aNDAs after the expiration of a patent.

Page 54: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

National Drug Code Number• Once a brand name receives FDA approval it is assigned

a unique National Drug Code (NDC) number, that appears on all drug stock labels and copies of duplicate prescription labels.

• The 10- to 11-character NDC number is made up of the following:• A four- or five-digit labeler code, identifying the manufacturer• A three- or four-digit product code, identifying the drug• A one- or two-digit package code, identifying package size and

type

• The NDC number plays a vital role for pharmacy technicians in preventing avoidable medication errors.

Page 55: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Information for Health Professionals

• Manufacturers must provide scientific information to the pharmacist with all prescription drug products.

• Product package insert (PPI) – is sent to the pharmacy from the wholesaler, contained in the stock medication.

• Table 3.2 outlines the specific order of the information on the PPI.

• The PPI is for the pharmacist and technician, not the patient.

• What is included in the PPI?• Black box warning is a warning statement on the PPI

indicating the possibility of serious or even life-threatening adverse reaction.

Page 56: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Information for Health Professionals

• The black box warning is indicated by a thick black border, surrounding the statement.

• This box is required by the FDA and is based on post surveillance studies.

• Data is collected via voluntarily submitting reports from pharmacists and physicians.

• Manufacturers must submit all reports to the FDA for further review and investigation.

• Why would the FDA issue a black box warning for a drug? What are some examples of drugs that have black box warnings?

Page 57: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Information for Consumers• Consumers are informed about side effects, adverse

reactions, and black box warnings through a patient package insert, or a supplemental printed medication guide called a MedGuide.

• The list of drugs requiring these information sheets and approval for the information on these sheets is developed by the FDA.

• Manufactures must provide patients with an easily understood format.

• The MedGuide is designed to do what?• Consumers should be encouraged to read all information

provided on drugs, and call or ask the pharmacist with any questions or concerns.

Page 58: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Postmarketing Surveillance• Drugs have a risk of toxicity, and because of this the FDA works

to continually gather information about approved medications, particularly any serious adverse reactions, not identified from research studies.

• An adverse drug reaction (ADR) – a negative consequence to a patient from taking a particular drug.

• The FDA established two nationwide postmarketing surveillance systems to allow for the reporting of adverse effects of certain medications.

• This adverse event reporting system (AERS) consists of the following:• MedWatch• VAERS• Quarterly newsletter:

www.paradigmcollege.net/pharmpractice5e/AERSdatabase

Page 59: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

MedWatch• Is a voluntary program that allows any healthcare

professional or consumer to report a serious adverse event associated with the use of any drug, biological device, or dietary supplement.

• Once reported information is gathered and assessed the FDA can respond in one of two ways:

• 1) issuing safety alerts for drugs, biologics, dietary supplements, and counterfeit drugs

• 2) request medication-labeling changes to the PPI• www.paradigmcollege.net/pharmpractice5e/MedWatch

Page 60: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Vaccine Adverse Event Reporting System (VAERS)• Vaccine Adverse Event Reporting System (VAERS) is

operated by the FDA and Centers for Disease Control and Prevention (CDC), to collect and analyze information on adverse events that occur after an immunization.

• This information is used to provide safest strategies of vaccine use and further reduce the rare risks associated with vaccines.

• VAERS reports can be made online www.paradigmcollege.net/pharmpractice5e/VAERSonline

• Via phone 1-800-822-7967• Or by mail of fax on a downloaded form

Page 61: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Risk Evaluation and Mitigation Strategies

• The FDA Amendments Act of 2007 gave the FDA the authority to require that a risk evaluation and mitigation strategy (REMS) be developed by drug manufacturers to ensure that the benefits outweighed the risks of their drugs.

• The development of MedGuides, for consumer education on high-risk drugs, was a strategy authorized by this amendment.

• Some drugs require more focused strategies. What examples are provided in your book?

• A centralized database in maintained by drug manufacturers to closely monitor patients on these high-risk drugs and periodic assessment reports are made to the FDA on the status of the REMS for each drug.

Page 62: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

iPLEDGE Program• This program was designed for two reasons:• 1) to prevent fetal exposure to the drug isotrentinoin• 2) to inform and educate all healthcare providers and

patients on drug risks and how to use this medication safely

• Pharmacies must be enrolled and certified to participate in this program; patients must also register and agree to meet conditions required during treatment.

• Contraceptive counseling is required to patients prior and during treatment with this drug.

• What sort of conditions must be met by the pharmacy and the patient in connection with this drug?

Page 63: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Transmucosal Immediate-Release Fentanyl (TIRF)• This program is designed to mitigate the risk of misuse,

abuse, addiction, overdose or severe complications due to various medication errors involving fentanyl.

• Prescribers, pharmacies and wholesalers must complete and education program, enrolling them and certifying them to participate in this program.

• Patients must sign an agreement with the prescriber; do not transfer the medication to others; if opioid therapy is discontinued the TIRF therapy must also be discontinued.

• Medication must be stored and discarded to prevent harm to children and pets.

Page 64: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Subutex and Suboxone• These medications are prescribed to treat opioid

dependence.• Certified physicians DEA number starts with an “x.”• The goals of this program are to mitigate the risks of

accidental overdose, misuse, and abuse and to inform patients of serious risks.

• Pharmacies that dispense these drugs must provide a MedGuide on each prescription and counsel on the safe use of the medication, including potential interactions.

• Patients should be counseled on proper storage of the medications to deter from theft or access by children.

Page 65: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Tikosyn• This antiarrhythmic drug can cause serious and

sometimes fatal arrhythmias.• The REMS program was developed to establish

dispensing and administering protocols.• Only physicians and pharmacies that have been enrolled,

educated and certified in the program can prescribe and dispense.

• Physicians must follow FDA-approved and manufacturer guidelines when providing this medication.

• A special stamp, provided by the manufacturer, must be placed on each prescription dispensed.

Page 66: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Drug Recall Process• After approval the FDA continues to monitor drugs on the

market, sometimes forcing the manufacturer to recall the product if it is contaminated, of poor quality or if it causes serious adverse reactions.

• When the risk is greater than the perceived benefit, the FDA may issue a drug recall and withdraw the drug from the market; other cases the manufacturer may be allowed to voluntarily withdraw the medication from the market.

• There are three classes of recalls. Class I is the most serious of recalls and requires immediate attention.

• www.paradigmcollege.net/pharmpractice5e/drugrecalls

Page 67: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Pharmaceutical Equivalence and Pharmaceutical Alternatives• In all states, technicians are allowed to substitute a

generic drug for a brand name drug as long as the generic drug is considered “equivalent.”

• The FDA Online Orange Book provides information on generic substitution.

• Pharmaceutically equivalent drug products are formulated to contain the same amount of active ingredient in the same dosage form in order to meet the same standards.

• Characteristics like shape, scoring configuration, release mechanisms, packaging, etc. can be different

Page 68: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Pharmaceutical Equivalence and Pharmaceutical Alternatives• Pharmaceutical alternative drug products contain the

same active therapeutic ingredient but contain different salts or are available in different dosage forms

• Approval must be obtained before a substitution occurs when involving different salts and dosage forms.

• Drugs are considered to be therapeutic equivalents only if they are pharmaceutical equivalents and if they can be expected to have the same clinical effect and safety profile.

• If the generic product is listed as an “A” category the drug is considered therapeutically equivalent and can be safely substituted; a “B” category has some discrepancy in its therapeutic effect and the product cannot be substituted.

Page 69: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Pharmaceutical Equivalence and Pharmaceutical Alternatives• Some physicians and patients do not like to substitute

brand name medications for generics.• The physician is then permitted to write “brand medically

necessary” on the prescription to see that the brand name medication is dispensed.

• Patients can request the brand name of a medication even if the physician didn’t indicate that it was necessary, this often results in a higher co-pay.

• Patients may also request a generic when the physician has noted “brand medically necessary”, though the physicians office should be contacted to approve the generic over the brand

Page 70: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Other Pharmacy Drug References• Physician’s Desk Reference• Drug Facts and Comparisons• American Drug Index• Micromedex• Handbook of Nonprescription Drugs• Remington: The Science and Practice of Pharmacy• Homeopathic: Pharmacopeia of the United States (HPUS)

Homeopathic Pharmacopeia of the United States Revision Service (HPRS)

• American Hospital Formulary Service• Stability of Compounded Formulations• The Lawrence Review of Natural Products

Page 71: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

This workforce solution was funded by a grant awarded by the U.S. Department of Labor’s Employment and Training Administration. The solution was created by the grantee and does not necessarily reflect the official position of the U.S. Department of Labor. The Department of Labor makes not guarantees, warranties, or assurances of any kind, express or implied, with respect to such information, including any information on linked sites and including, but not limited to, accuracy of the information or tis completeness, timeliness, usefulness, adequacy, continued availability, or ownership.

This work by Mineral Area College is licensed under the Creative Commons Attribution 4.0 International License.

Page 72: CHAPTER 3 Drug Development Created by Jennifer Majeske, Mineral Area College.

Created by Jennifer Majeske, Mineral Area College

Resources• Picture on slide 6

• Four colors of pills by Sage Ross is licensed under CC BY

• Picture on slide 9• Question marks by clipartcottage is licensed under CC BY

• Picture on slide 10• Syringe by Wikimedia Commons is licensed under CC BY

• YouTube on slide 13• Alexander Fleming, the inventor of Penicillin 1888-1955 by Dan

Izzo